Health Care: Drugs

Zogenix Inc (ZGNX: NASDAQ)

$12.55 -0.5 | -3.83%
12/05/16 - 01:25 PM ET
Company Profile
Price and Volume
Recent Price 13.05
52 Week High 15.49
52 Week Low 7.33
Avg. Daily Vol. (Mil) 0.21
Beta (3 year) 1.65
Share Related Items
Mkt Cap (Mil) 323.52
Shares Out (Mil) 24.79
Float (Mil) 17.69
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 8.20
Current Ratio 9.60
LT Debt/ Equity 0.15
Total Debt / Equity 0.15
Valuation Ratios
Price Earnings n.a.
Price/Sales 13.51
Price/Book 2.28
Price/Cash Flow -6.10
Per Share Data
Earnings -2.37
Sales 0.97
Book Value 5.72
Cash Flow -2.12
Business Summary
Zogenix Inc is a pharmaceutical company engaged in commercializing & developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.
General Information
5858 Horton Street
Suite 455
Emeryville, CA 94608
www.zogenix.com
Industry : Drugs
Sector: Health Care
Employees: 62
CEO: Steven J. Farr,PhD
Short Interest
Current Month (Mil) 4.48
Previous Month (Mil) 4.13
Short Interest Ratio (Days) 20.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -21.50
Return on Investments -33.60
Profitability
Gross Margin 20.60
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ZGNX

Latest ZGNX Headlines from TheStreet

More Financial News for ZGNX

Press Releases for ZGNX

See All Press Releases

Partner Headlines for ZGNX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter